Head and neck Recurrent thyroid cancer: a molecularbased therapeutic breakthrough Review: (pp. 235-240) Ambrosini V, Marzola MC, Rubello D, Fanti S. Ga-68somatostatin analogues PET and F-18-DOPA PET in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2010; 37:46-48. Barollo S, Pennelli G, Vianello F, Fernando SW, et al. BRAF in primary and recurrent papillary thyroid cancers: the relationship with I-131 and 2-[F-18]fluoro-2-deoxy-Dglucose uptake ability. Eur